Clinical Trial Update: Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

View source ↗

Summary

This completed clinical trial (Study P04600) evaluated whether proactive management of side effects improves treatment compliance in melanoma patients receiving…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Intron A (interferon alfa-2b)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Melanoma | Status: COMPLETED | Results posted: 2013-10-28